The tumor sphere formation assays also revealed a reduction in spheroid size upon treatment with DAPT (1 μM) or anti-Jagged1 antibody (2 μg/ml) in combination with COMP (20 μg/ml), compared to COMP-treated cells, for SKOV3 (COMP Vs. The gene discussed is COMP; the disease is neoplasm.